Fiona Godlee, editor in chief, British Medical Journal, London

In 2009 a flu pandemic started: The H1N1 virus, more commonly known as the “swine flu” was on the rise. The British government spent over 500 million pounds to stockpile the anti-viral drug oseltamivir, better known under its brand name “Tamiflu”. The problem is: Oseltamivir seems to not do anything to significantly reduce the effects of the flu...

How is it possible that governments worldwide spent millions of dollars on a drug that had not been sufficiently proven to be effective? This is the story at the heart of Fiona Godlee’s talk “Conflicts of Interest in Public Health”.


by Alcibiades (Own Work) [Public domain], via Wikimedia Commons

ScienceUncut - Science Podcast by Volkswagen Foundation